Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

JPMorgan’s net income soared 50% to more than $14 billion in the fourth quarter as the bank’s profit and revenue easily beat ...

In a report released today, John McDonald CFA from Truist Financial assigned a Hold rating to JPMorgan Chase & Co. (JPM – Research Report).

In a report released today, Glenn Schorr from Evercore ISI maintained a Buy rating on JPMorgan Chase & Co. (JPM – Research Report), with a ...

Spain’s Almirall has announced strategic plans at the 43rd JP Morgan Healthcare Conference based on expected double-digit growth within the dermatological area for Almirall’s psoriasis and atopic ...

Yesterday, spots of pink could be spotted on the streets of San Francisco, and it wasn’t a coincidence. Members of the ...

Teladoc Health faces pressure in a saturated telehealth market, but it's hard to ignore the virtual care company's massive ...

It's not just JPMorgan Chase. Across the industry, banks are rethinking their remote-work policies — but experts say it won't ...

Analysis of JPMorgan Chase and Goldman Sachs Q4 2024 earnings forecasts, including key metrics, analyst expectations and ...

Almirall, a global pharmaceutical company dedicated to medical dermatology, is participating in the 2025 JPMorgan HealthCare ...

Databricks, a tech giant with two Romanians among its founders, secured USD 5 billion in funding from creditors such as Blackstone, Apollo Global Management Inc., and Blue Owl Capital Inc., marking ...